结节性黑色素瘤的临床试验
总计6665个结果
-
Iovance Biotherapeutics, Inc.主动,不招人
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Children's Oncology Group; Cancer and... 和其他合作者主动,不招人
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; SWOG Cancer Research Network完全的
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute完全的
-
Novartis Pharmaceuticals终止
-
F. Stephen Hodi, MDMedImmune LLC完全的
-
The Christie NHS Foundation TrustNational Institute for Health Research, United Kingdom终止
-
Linkoeping UniversityKarolinska Institutet; Region Östergötland; Region Stockholm; Kronoberg County Council; Landstinget...完全的
-
Biocad主动,不招人黑色素瘤 | 黑色素瘤转移俄罗斯联邦, 白俄罗斯
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer Institute终止
-
Ludwig Institute for Cancer Research终止
-
Ludwig Institute for Cancer ResearchCancer Research Institute (CRI)完全的
-
Bristol-Myers Squibb完全的
-
Hoffmann-La Roche完全的恶性黑色素瘤美国, 澳大利亚, 巴西, 西班牙, 南非, 乌克兰, 波斯尼亚和黑塞哥维那
-
Nektar TherapeuticsImaginAb, Inc.撤销
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer Institute撤销
-
Craig L Slingluff, JrNational Cancer Institute (NCI)完全的
-
BioNTech US Inc.Apexigen, Inc.终止
-
Craig L Slingluff, JrNational Cancer Institute (NCI)完全的
-
Nantes University HospitalUMR892完全的
-
Eli Lilly and Company完全的
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics Inc.完全的
-
Osaka UniversityMerck Sharp & Dohme LLC; ISHIHARA SANGYO KAISHA,LTD. Japan未知
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的